Oral medication is leading choice for multiple sclerosis treatment: Study
The study states that oral medication is the preferred choice for treating multiple sclerosis due to convenience, promotion, and approval by health insurers. | Health
Stay updated with breaking news from Multiple Sclerosis Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study states that oral medication is the preferred choice for treating multiple sclerosis due to convenience, promotion, and approval by health insurers. | Health
Webinar to take place on Monday, June 5, 2023 at 12:30 PM ETNEW YORK, May 25, 2023) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes
The $7.3 million award from the National Institute of Neurological Disorders and Stroke will support the professor’s research.
Nimbus Therapeutics Appoints Nathalie Franchimont, M.D., Ph.D., as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace
-- Second Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’ adherence to PoNS® therapy for gait... | May 17, 2022